Liquidia (NASDAQ:LQDA) Reaches New 12-Month High - Here's Why

Key Points

• Liquidia shares hit a new 52-week high, trading as high as $62.37 after closing at $60.10 the prior day. The move came alongside elevated volume, suggesting strong near-term investor interest.
• Analysts remain upbeat on the stock, with a “Moderate Buy” consensus and recent price-target increases from firms including HC Wainwright and Needham. Several analysts now see upside well above current levels.
• Recent earnings were strong, as Liquidia reported $0.52 EPS versus $0.41 expected and revenue of $132.87 million, far above estimates and up sharply year over year. However, recent insider selling by the CEO and a director may temper sentiment somewhat.

Liquidia Corporation (NASDAQ:LQDA - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $62.37 and last traded at $61.9890, with a volume of 285703 shares. The stock had previously closed at $60.10.

Key Liquidia News

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Liquidia announced that CEO Dr. Roger Jeffs and COO/CFO Michael Kaseta will present a business update at the Jefferies Global Healthcare Conference on June 3. A conference appearance can raise visibility and may signal management confidence in the company’s outlook. Article: Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
• Positive Sentiment: Wall Street sentiment remains constructive, with analysts maintaining a “Moderate Buy” consensus and some firms recently lifting price targets. That supports the stock’s recent strength after a strong earnings report. Article: Liquidia Corporation NASDAQ: LQDA Given Average Recommendation of "Moderate Buy" by Analysts
• Neutral Sentiment: Recent insider sales by CEO Roger Jeffs, including another 25,000-share sale, were made under a pre-arranged 10b5-1 plan. The sales may be viewed as routine, but multiple insider disposals can still weigh on investor sentiment. Article: Liquidia NASDAQ: LQDA CEO Roger Jeffs Sells 25,000 Shares
• Neutral Sentiment: Director Raman Singh also sold shares recently, adding to the pattern of insider selling. While not necessarily a fundamental red flag, it can create near-term caution for traders. Article: Liquidia NASDAQ: LQDA Director Raman Singh Sells 29,494 Shares of Stock

Analyst Ratings Changes

Several research analysts recently issued reports on LQDA shares. HC Wainwright increased their price target on shares of Liquidia from $55.00 to $67.00 and gave the stock a "buy" rating in a research report on Tuesday, May 12th. Lifesci Capital raised shares of Liquidia to a "strong-buy" rating in a research note on Thursday, March 5th. Raymond James Financial reaffirmed a "strong-buy" rating on shares of Liquidia in a research note on Thursday, March 5th. Needham & Company LLC upped their price objective on shares of Liquidia from $54.00 to $70.00 and gave the stock a "buy" rating in a research note on Monday, May 11th. Finally, Jefferies Financial Group reaffirmed a "buy" rating and set a $60.00 price objective on shares of Liquidia in a research note on Monday, May 11th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Liquidia currently has an average rating of "Moderate Buy" and a consensus target price of $49.33.

Liquidia Price Performance

The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. The stock has a market capitalization of $5.61 billion, a P/E ratio of 450.38 and a beta of 0.41. The company's 50 day simple moving average is $43.00 and its two-hundred day simple moving average is $37.80.

Liquidia (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business had revenue of $132.87 million for the quarter, compared to analysts' expectations of $119.44 million. Liquidia's revenue for the quarter was up 4187.1% compared to the same quarter last year. As a group, equities analysts expect that Liquidia Corporation will post 2.97 EPS for the current fiscal year.

Insider Activity at Liquidia

In other news, Director Raman Singh sold 29,494 shares of the stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $60.13, for a total transaction of $1,773,474.22. Following the sale, the director directly owned 38,755 shares of the company's stock, valued at $2,330,338.15. This represents a 43.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Roger Jeffs sold 25,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $60.38, for a total transaction of $1,509,500.00. Following the sale, the chief executive officer directly owned 1,048,095 shares in the company, valued at $63,283,976.10. This trade represents a 2.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,127,207 shares of company stock valued at $50,967,227 over the last three months. 25.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On Liquidia

A number of hedge funds and other institutional investors have recently bought and sold shares of LQDA. Farallon Capital Management LLC boosted its stake in Liquidia by 102.1% in the third quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company's stock valued at $194,783,000 after acquiring an additional 4,326,876 shares during the last quarter. TCG Crossover Management LLC bought a new position in Liquidia in the third quarter valued at approximately $38,887,000. Caprock Group LLC bought a new position in Liquidia in the third quarter valued at approximately $37,114,000. MPM Bioimpact LLC boosted its stake in Liquidia by 600.4% in the fourth quarter. MPM Bioimpact LLC now owns 1,400,869 shares of the company's stock valued at $48,316,000 after acquiring an additional 1,200,869 shares during the last quarter. Finally, Voloridge Investment Management LLC bought a new position in Liquidia in the third quarter valued at approximately $12,571,000. 64.54% of the stock is owned by institutional investors.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.